Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 27, 2026

A Streamlined, Label-Free Real-Time 50% Tissue Culture Infectious Dose (TCID50) Assay using Impedance for Automated Viral Titer Quantification
08:01

A Streamlined, Label-Free Real-Time 50% Tissue Culture Infectious Dose (TCID50) Assay using Impedance for Automated Viral Titer Quantification

Published on: January 9, 2026

Calculating HIV-1 infectious titre using a virtual TCID(50) method.

Yong Gao1, Immaculate Nankya, Awet Abraha

  • 1Division of Infectious Diseases, Department of Medicine, Case Western Reserve University, Cleveland, OH, USA.

Methods in Molecular Biology (Clifton, N.J.)
|November 21, 2008
PubMed
Summary

A new virtual TCID(50) method offers a faster, cell-free way to measure infectious HIV-1 levels. This technique compares reverse transcriptase activity, providing results comparable to traditional methods for HIV research.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dual engagement of Spike and ACE2 by annexin A5 contributes to pleiotropic SARS-CoV-2 inhibition.

Scientific reports·2026
Same author

The adult nasal mucosa is defined by distinct immune profiles that modulate in-vitro SARS-CoV-2 infection.

Respiratory research·2026
Same author

Influenza A and B Viral Shedding in Adults Immunized with Live Attenuated Influenza Vaccine.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same author

Comprehensive analysis of gp120 glycosylation to explore differences between transmitter/founder and chronic HIV-1 isolates.

Glycobiology·2026
Same author

The adult nasal mucosa is defined by distinct immune profiles that modulate in-vitro SARS-CoV-2 infection.

Research square·2026
Same author

Correction: Transmitted/founder (T/F) HIV-1 derived from sexual contact exhibits greater transmission fitness in human cervical tissue than T/F HIV-1 from blood-to-blood contact: Unique glycan profiles on T/F envelopes associated with transmission phenotypes.

PLoS pathogens·2025

Area of Science:

  • Virology
  • Molecular Biology
  • Immunology

Background:

  • Accurate quantification of infectious Human Immunodeficiency Virus type 1 (HIV-1) is crucial for studying viral replication and fitness.
  • The standard method, tissue culture dose for 50% infectivity (TCID(50)), is time-consuming and labor-intensive, requiring cell cultures and several weeks for results.

Purpose of the Study:

  • To develop and validate a rapid, cell-free surrogate method for measuring infectious HIV-1 titers.
  • To provide a more efficient alternative to the traditional TCID(50) assay for HIV-1 quantification.

Main Methods:

  • Introduction of the virtual TCID(50) technique, a novel cell-free assay.
  • Estimation of infectious titer by comparing reverse transcriptase (RT) activity in virus stocks to reference viruses with known TCID(50) values.

More Related Videos

Lentivirus Production
11:42

Lentivirus Production

Published on: October 2, 2009

Measurement of In Vitro Integration Activity of HIV-1 Preintegration Complexes
10:34

Measurement of In Vitro Integration Activity of HIV-1 Preintegration Complexes

Published on: February 22, 2017

Related Experiment Videos

Last Updated: Jun 27, 2026

A Streamlined, Label-Free Real-Time 50% Tissue Culture Infectious Dose (TCID50) Assay using Impedance for Automated Viral Titer Quantification
08:01

A Streamlined, Label-Free Real-Time 50% Tissue Culture Infectious Dose (TCID50) Assay using Impedance for Automated Viral Titer Quantification

Published on: January 9, 2026

Lentivirus Production
11:42

Lentivirus Production

Published on: October 2, 2009

Measurement of In Vitro Integration Activity of HIV-1 Preintegration Complexes
10:34

Measurement of In Vitro Integration Activity of HIV-1 Preintegration Complexes

Published on: February 22, 2017

Main Results:

  • The virtual TCID(50) values were found to be comparable to the actual infectious TCID(50) values.
  • The new method significantly simplifies the process of HIV-1 titration.

Conclusions:

  • The virtual TCID(50) technique provides a rapid and accurate cell-free method for quantifying infectious HIV-1.
  • This approach is particularly advantageous for high-throughput studies involving numerous HIV-1 isolates, accelerating research in HIV pathogenesis and therapeutic development.